CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Teal Health›
News
Teal Health

Teal Health

Teal Health offers the FDA-authorized Teal Wand for at-home cervical cancer screening.

San Francisco, CA, US🇺🇸
Founded
2020
Loading
Overview
Compare
Fundraising
Employees
News
Library

Latest News About Teal Health

Teal Health Raises $22 Million Series A to Expand Access to the Most Accurate FDA-Authorized At-Home HPV Cervical Cancer Screening

Teal Health

Teal Health Raises $22 Million Series A to Expand Access to the Most Accurate FDA-Authorized At-Home HPV Cervical Cancer Screening

The round, led by .406 Ventures, funds expanding payor, health system, employer, and provider partnerships ahead of broad insurance...

Sep 22, 2026

Teal Health Works with UC Davis Health to Advance At-Home Cervical Cancer Screening Within Health Systems

Teal Health

Teal Health Works with UC Davis Health to Advance At-Home Cervical Cancer Screening Within Health Systems

The NIH SBIR-funded pilot studies how at-home HPV self-collection integrates into health system care and reaches women due or overdue for...

Jul 23, 2026

Teal Health and WashU Medicine Collaborate to Expand Cervical Cancer Screening in Underserved Communities

Teal Health

Teal Health and WashU Medicine Collaborate to Expand Cervical Cancer Screening in Underserved Communities

The pilot study brings at-home HPV self-collection kits to women through trusted community events across Illinois and Missouri.

May 28, 2026

75% of Women Are Likely Skipping Healthcare Because It's Too Hard to Fit Into Their Lives, New Report Finds

Teal Health

75% of Women Are Likely Skipping Healthcare Because It's Too Hard to Fit Into Their Lives, New Report Finds

Teal Health's State of Her Health 2026 report finds that time, access, and outdated systems are driving women away from care.

Feb 19, 2026

Teal Health Expands Nationwide, Bringing the Only FDA-Authorized Device for At-Home Cervical Cancer Screening to All 50 States

Teal Health

Teal Health Expands Nationwide, Bringing the Only FDA-Authorized Device for At-Home Cervical Cancer Screening to All 50 States

At-home cervical cancer screening with the FDA-authorized Teal Wand becomes available to women across all 50 U.S. states.

Jan 7, 2026